Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer. (PubMed, Genes Chromosomes Cancer) - Sep 9, 2026 - "Our study demonstrates the histologic and molecular heterogeneity of NRG1 fusion-positive NSCLC, encompassing mucinous and enteric variants of adenocarcinoma. Responses to afatinib were variable, underscoring the need for more effective therapies, including zenocutuzumab and emerging agents."
Clinical • Journal • Retrospective data • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • CD74 • NRG1 • PD-L1
|
|
Fatih Kemik; Fatih Selçukbiricik; Mehmet Haluk Yücel; Nazan Demir; Ömer Fatih Ölmez
|